Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11469541 [patent_doc_number] => 20170056324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-02 [patent_title] => 'TUBE FEED FORMULATIONS AND METHODS FOR USING SAME' [patent_app_type] => utility [patent_app_number] => 15/349336 [patent_app_country] => US [patent_app_date] => 2016-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18700 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349336 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/349336
TUBE FEED FORMULATIONS AND METHODS FOR USING SAME Nov 10, 2016 Abandoned
Array ( [id] => 11619741 [patent_doc_number] => 20170129929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-11 [patent_title] => 'LEDGF PEPTIDES AND FORMULATIONS THEREOF FOR TREATMENT OF DEGENERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 15/348970 [patent_app_country] => US [patent_app_date] => 2016-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 20176 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15348970 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/348970
LEDGF peptides and formulations thereof for treatment of degenerative disorders Nov 9, 2016 Issued
Array ( [id] => 15631945 [patent_doc_number] => 10588940 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-17 [patent_title] => Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders [patent_app_type] => utility [patent_app_number] => 15/773498 [patent_app_country] => US [patent_app_date] => 2016-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 18 [patent_no_of_words] => 10263 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15773498 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/773498
Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders Nov 3, 2016 Issued
Array ( [id] => 13287695 [patent_doc_number] => 10155020 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-12-18 [patent_title] => Compositions and methods for treating hepatitis B [patent_app_type] => utility [patent_app_number] => 15/343473 [patent_app_country] => US [patent_app_date] => 2016-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 15024 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15343473 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/343473
Compositions and methods for treating hepatitis B Nov 3, 2016 Issued
Array ( [id] => 13955631 [patent_doc_number] => 20190054159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-21 [patent_title] => PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT, PROCESS FOR ITS PREPARATION, AND ITS USE [patent_app_type] => utility [patent_app_number] => 15/773048 [patent_app_country] => US [patent_app_date] => 2016-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7022 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15773048 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/773048
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT, PROCESS FOR ITS PREPARATION, AND ITS USE Oct 31, 2016 Abandoned
Array ( [id] => 11456000 [patent_doc_number] => 20170049906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-23 [patent_title] => 'TRANSLOCATION OF NON-NATURAL CHEMICAL ENTITIES THROUGH ANTHRAX PROTECTIVE ANTIGEN PORE' [patent_app_type] => utility [patent_app_number] => 15/340437 [patent_app_country] => US [patent_app_date] => 2016-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18768 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15340437 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/340437
TRANSLOCATION OF NON-NATURAL CHEMICAL ENTITIES THROUGH ANTHRAX PROTECTIVE ANTIGEN PORE Oct 31, 2016 Abandoned
Array ( [id] => 15129911 [patent_doc_number] => 10478392 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-19 [patent_title] => Peptide and cosmetic composition comprising same for preventing skin aging or skin wrinkle formation [patent_app_type] => utility [patent_app_number] => 15/771222 [patent_app_country] => US [patent_app_date] => 2016-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1985 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15771222 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/771222
Peptide and cosmetic composition comprising same for preventing skin aging or skin wrinkle formation Oct 26, 2016 Issued
Array ( [id] => 11750376 [patent_doc_number] => 09708378 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-18 [patent_title] => 'Peptides derived from NCAPG2 and their use' [patent_app_type] => utility [patent_app_number] => 15/285873 [patent_app_country] => US [patent_app_date] => 2016-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 44 [patent_no_of_words] => 10894 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15285873 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/285873
Peptides derived from NCAPG2 and their use Oct 4, 2016 Issued
Array ( [id] => 13479087 [patent_doc_number] => 20180291086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-11 [patent_title] => LIPOPLEXES FORMULATED FOR CATALYTIC DELIVERY [patent_app_type] => utility [patent_app_number] => 15/766088 [patent_app_country] => US [patent_app_date] => 2016-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18078 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15766088 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/766088
LIPOPLEXES FORMULATED FOR CATALYTIC DELIVERY Oct 4, 2016 Abandoned
Array ( [id] => 11400258 [patent_doc_number] => 20170020797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-26 [patent_title] => 'COMPOSITION' [patent_app_type] => utility [patent_app_number] => 15/284586 [patent_app_country] => US [patent_app_date] => 2016-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6449 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15284586 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/284586
Composition Oct 3, 2016 Issued
Array ( [id] => 13461681 [patent_doc_number] => 20180282383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => SMALL MOLECULES BLOCKING HISTONE READER DOMAINS [patent_app_type] => utility [patent_app_number] => 15/765344 [patent_app_country] => US [patent_app_date] => 2016-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22180 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15765344 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/765344
SMALL MOLECULES BLOCKING HISTONE READER DOMAINS Sep 29, 2016 Abandoned
Array ( [id] => 11400422 [patent_doc_number] => 20170020960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-26 [patent_title] => 'LIQUID FORMULATIONS OF TUMOR NECROSIS FACTOR-BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 15/283001 [patent_app_country] => US [patent_app_date] => 2016-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4106 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15283001 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/283001
LIQUID FORMULATIONS OF TUMOR NECROSIS FACTOR-BINDING PROTEINS Sep 29, 2016 Abandoned
Array ( [id] => 14594177 [patent_doc_number] => 10350265 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-16 [patent_title] => Therapeutic applications of Smad7 [patent_app_type] => utility [patent_app_number] => 15/282022 [patent_app_country] => US [patent_app_date] => 2016-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13447 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15282022 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/282022
Therapeutic applications of Smad7 Sep 29, 2016 Issued
Array ( [id] => 16604654 [patent_doc_number] => 10905637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-02 [patent_title] => Peptide nanoparticles and uses therefor [patent_app_type] => utility [patent_app_number] => 15/279687 [patent_app_country] => US [patent_app_date] => 2016-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17256 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15279687 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/279687
Peptide nanoparticles and uses therefor Sep 28, 2016 Issued
Array ( [id] => 16198634 [patent_doc_number] => 10723784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-28 [patent_title] => Compositions and methods for preparing a subject for organ or non-organ implantation [patent_app_type] => utility [patent_app_number] => 15/279258 [patent_app_country] => US [patent_app_date] => 2016-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 14121 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15279258 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/279258
Compositions and methods for preparing a subject for organ or non-organ implantation Sep 27, 2016 Issued
Array ( [id] => 13885505 [patent_doc_number] => 10195284 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-05 [patent_title] => Compositions and methods for controlled localized delivery of bone forming therapeutic agents [patent_app_type] => utility [patent_app_number] => 15/276382 [patent_app_country] => US [patent_app_date] => 2016-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 88 [patent_no_of_words] => 40522 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15276382 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/276382
Compositions and methods for controlled localized delivery of bone forming therapeutic agents Sep 25, 2016 Issued
Array ( [id] => 13805083 [patent_doc_number] => 10179803 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-15 [patent_title] => Methods for inhibiting immune complex formation in a subject [patent_app_type] => utility [patent_app_number] => 15/269537 [patent_app_country] => US [patent_app_date] => 2016-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 10 [patent_no_of_words] => 18677 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15269537 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/269537
Methods for inhibiting immune complex formation in a subject Sep 18, 2016 Issued
Array ( [id] => 11628761 [patent_doc_number] => 20170138950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'IDENTIFICATION OF CANCER PROTEIN BIOMARKERS USING PROTEOMIC TECHNIQUES' [patent_app_type] => utility [patent_app_number] => 15/268134 [patent_app_country] => US [patent_app_date] => 2016-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16800 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15268134 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/268134
Identification of cancer protein biomarkers using proteomic techniques Sep 15, 2016 Issued
Array ( [id] => 11348900 [patent_doc_number] => 20160367640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'RAPID-ACTING INSULIN COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 15/259101 [patent_app_country] => US [patent_app_date] => 2016-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8068 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15259101 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/259101
Rapid-acting insulin compositions Sep 7, 2016 Issued
Array ( [id] => 15281781 [patent_doc_number] => 10513545 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-24 [patent_title] => Fusion polypeptide in which anti-inflammatory polypeptide and ferritin monomer fragment are bound and pharmaceutical composition for preventing and treating inflammatory diseases, containing same as active ingredient [patent_app_type] => utility [patent_app_number] => 15/757580 [patent_app_country] => US [patent_app_date] => 2016-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 32 [patent_no_of_words] => 11866 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15757580 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/757580
Fusion polypeptide in which anti-inflammatory polypeptide and ferritin monomer fragment are bound and pharmaceutical composition for preventing and treating inflammatory diseases, containing same as active ingredient Sep 1, 2016 Issued
Menu